LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Name LLYON
Rank No.1196
Market Cap $5.58M
Fully Diluted Market Cap $5.58M
Market Share %
Trading Vol/Market Cap (24H) 46,387.56%
Circulation Supply 4.38K
Max Supply 0
Total Supply 4,375.16156512
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1318.8047981537145, 2026-10-20
Lowest Price 712.8133541417105, 2025-09-25
Public Blockchain LLYON
Introduction li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(LLYON) |
Sell(LLYON) |
Net Inflow |
| Big |
1.789K |
0.000 |
1.789K |
| Medium |
828.363 |
2.342K |
-1513.996 |
| Small |
4.723K |
6.286K |
-1563.528 |
| Total |
7.340K |
8.628K |
-1288.493 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.